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Tuesday, April 5, 2022
During this COVID-19 pandemic and other future events, the CDM has been and will continue
to be a source of reliable information, education and models for mitigation, preparedness,
response, and recovery. We hope this informational document has helped provide you
filtered and actionable information. As the pace of new information and changes occur, we
will evaluate the current once per week to determine if this information should be provided on
a more frequent basis.

David Markenson, M.D., M.B.A.
Director
Center for Disaster Medicine

COVID-19 Statistic

Total Cases

Total Deaths

Total Vaccine Doses
Admin.

Worldwide

493,667,409

6,169,813

11,003,381,292

United States

81,495,644

997,126

560,518,319

New Jersey

2,204,645

33,259

16,853,597

New York

5,010,041

68,007

38,442,440

Connecticut

738,544

10,779

7,421,163

Information as of 4/5/22 at 0600 EDT. Source: https://coronavirus.jhu.edu/map.html

United States COVID-19 Case Map / GIS

Center for Disaster Medicine Updates
•
•
•

Coordinating and overseeing COVID-19 screenings at NYMC campus.
Continue to partner with local organizations such as Westchester Department of Emergency
Services and Westchester Medical Center to ensure ongoing collaboration with all public
safety agencies.
Coordinating volunteers to support local public health response to COVID-19.

•
•
•
•
•
•

Conducting research and analysis of current events and COVID-19 response to identify
strengths and areas for improvement in other regions.
Updating and developing new programs to provide enhanced education on public health
emergencies including pandemics.
Exploring course development opportunities in infection prevention and control for frontline
responders in the hospital and in the field.
Serving as a source of information for COVID-19 related concerns or questions regarding
public health, emergency medical service (EMS), public safety and healthcare response.
Local networking and pandemic response analysis for New York’s tri-state area, using firstperson experiences to highlight current trends.
On March 30, 2022, CDM staff George W. Contreras was keynote speaker for Venezuelan
Medical Society in Emergencies and Disasters virtual symposium. He discussed the NYC
response regarding COVID-19 from a public health and emergency management
perspective.

The White House
On April 4, 2022, Press Secretary Jen Psaki released a statement regarding the COVID-19
Bipartisan Funding Proposal- The Administration requested $22.5 billion to continue to provide
critical protections like vaccines, boosters, treatments, and tests to people here at home and for
help putting shots in arms around the world. Every dollar we requested is essential and we will
continue to work with Congress to get all of the funding we need.
https://www.whitehouse.gov/briefing-room/statements-releases/2022/04/04/statement-frompress-secretary-jen-psaki-on-the-covid-19-bipartisan-funding-proposal/
On March 30, 2022, President Biden provided an update regarding the status of the Country’s
Fight Against COVID-19- President Biden including the launch of a new government website
which will provide all the information regarding covid in one site- www.covid.gov.
https://www.whitehouse.gov/briefing-room/speeches-remarks/2022/03/30/remarks-by-presidentbiden-on-the-status-of-the-countrys-fight-against-covid-19/
On March 30, 2022, Biden Administration Launches COVID.gov, a New One-Stop Shop Website
for Vaccines, Tests, Treatments, Masks, and the Latest COVID-19 Information- a new website
was launched in an effort to consolidate information for consumers.
https://www.whitehouse.gov/briefing-room/statements-releases/2022/03/30/fact-sheet-bidenadministration-launches-covid-gov-a-new-one-stop-shop-website-for-vaccines-tests-treatmentsmasks-and-the-latest-covid-19-information/
The official website of the White House will deliver updated information as the country grapples
with converging crises. This will include actions to control the COVID-19 pandemic, provide
economic relief, tackle climate change, and advance racial equity and civil rights, as well as
immediate actions to reform our immigration system and restore America’s standing in the world.
This website will provide all information in one central location.
https://www.whitehouse.gov
Health and Human Services (HHS)
On April 4, 2022, Biden-Harris Administration Announced a New Way for Medicare Beneficiaries
to Get Free Over-the-Counter COVID-19 Tests- The Biden-Harris Administration is announced
that more than 59 million Americans with Medicare Part B, including those enrolled in a Medicare
Advantage plan, now have access to Food and Drug Administration (FDA) approved, authorized,
or cleared over-the-counter COVID-19 tests at no cost. People with Medicare can get up to eight
tests per calendar month from participating pharmacies and health care providers for the
duration of the COVID-19 public health emergency.
https://www.hhs.gov/about/news/2022/04/04/biden-harris-administration-announces-new-waymedicare-beneficiaries-get-free-over-counter-covid-19-tests.html
For the latest COVID-19 information from HHS
https://www.hhs.gov/about/news/coronavirus/index.html
For the latest COVID-19 information from HHS
https://www.hhs.gov/about/news/coronavirus/index.html

National Institutes of Health (NIH)
On March 31, 2022, NIH experts discuss controlling COVID-19 in commentary on herd
immunity- Achieving classical herd immunity against SARS-CoV-2, the virus that causes COVID19, may not be attainable, according to a new perspective published in The Journal of Infectious
Diseases. However, widespread use of currently available public health interventions to prevent
and control COVID-19 will enable resumption of most activities of daily life with minimal
disruption, the authors note. Anthony S. Fauci, M.D., director of the National Institute of Allergy
and Infectious Diseases (NIAID), part of NIH, David M. Morens, M.D., senior scientific advisor to
the NIAID director, and Gregory K. Folkers, chief of staff to the NIAID director, authored the
perspective.
https://www.nih.gov/news-events/news-releases/nih-experts-discuss-controlling-covid-19commentary-herd-immunity
On March 31, 2022, NIH began clinical trial evaluating second COVID-19 booster shots in
adults- A Phase 2 clinical trial evaluating various additional COVID-19 booster shots has begun
enrolling adult participants in the United States. The trial aims to understand if different vaccine
regimens—prototype and variant vaccines alone and in combinations—can broaden immune
responses in adults who already have received a primary vaccination series and a first booster
shot. The study, known as the COVID-19 Variant Immunologic Landscape (COVAIL) trial, is
sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the
National Institutes of Health.
https://www.nih.gov/news-events/news-releases/nih-begins-clinical-trial-evaluating-secondcovid-19-booster-shots-adults
View the latest COVID-19 information from NIH.
https://www.nih.gov/coronavirus

United States Food and Drug Administration (FDA)
On April 1, 2022, 425 tests and sample collection devices are authorized by the FDA
under emergency use authorizations (EUAs). These include 293 molecular tests and
sample collection devices, 84 antibody and other immune response tests and 48 antigen
tests. There are 74 molecular authorizations and 1 antibody authorization that can be
used with home-collected samples. There is one EUA for a molecular prescription athome test, two EUAs for antigen prescription at-home tests, 15 EUAs for antigen overthe-counter (OTC) at-home tests, and three for molecular OTC at-home tests. The FDA
has authorized 28 antigen tests and nine molecular tests for serial screening programs.
The FDA has also authorized 910 revisions to EUA authorizations.
https://www.fda.gov/news-events/press-announcements/fda-roundup-april-1-2022

On March 29, 2022, FDA Authorizes Second Booster Dose of Two COVID-19 Vaccines
for Older and Immunocompromised Individuals- the U.S. Food and Drug Administration
authorized a second booster dose of either the Pfizer-BioNTech or the Moderna COVID19 vaccines for older people and certain immunocompromised individuals. The FDA
previously authorized a single booster dose for certain immunocompromised individuals
following completion of a three-dose primary vaccination series. This action will now make
a second booster dose of these vaccines available to other populations at higher risk for
severe disease, hospitalization and death. Emerging evidence suggests that a second
booster dose of an mRNA COVID-19 vaccine improves protection against severe COVID19 and is not associated with new safety concerns.
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fdaauthorizes-second-booster-dose-two-covid-19-vaccines-older-and
For the latest overall FDA information about COVID-19.
https://www.fda.gov/emergency-preparedness-and-response/counterterrorism-andemerging-threats/coronavirus-disease-2019-covid-19

Centers for Disease Control and Prevention (CDC)
On April 4, 2022, the CDC announced updates regarding testing strategies for SARSCoV2- Effective April 4, 2022, HHS and CDC announced revisions to COVID-19
laboratory reporting guidance. Reporting of negative results for non-NAAT tests (rapid or
antigen test results) is no longer required. However, testing sites must still report data for
all positive diagnostic and screening testing completed for each individual test.
https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/sars-cov2-testingstrategies.html
On April 2, 2022, the CDC provided updated information regarding how to stay update
with the COVID-19 vaccines.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/stay-up-to-date.html
On March 31, 2022, New CDC data illuminate youth mental health threats during the
COVID-19 pandemic- New CDC analyses, published today, shine additional light on the
mental health of U.S. high school students during the COVID-19 pandemic, including a
disproportionate level of threats that some students experienced. According to the new
data, in 2021, more than a third (37 percent) of high school students reported they
experienced poor mental health during the COVID-19 pandemic, and 44 percent reported
they persistently felt sad or hopeless during the past year.
https://www.cdc.gov/media/releases/2022/p0331-youth-mental-health-covid-19.html
CDC provides updated information about the variants in the United States- The emerging
variants CDC is closely monitoring have mutations in the virus genome that alter the
characteristics and cause the virus to act differently in ways that are significant to public
health (e.g., causes more severe disease, spreads more easily between humans,
requires different treatments, changes the effectiveness of current vaccines). It’s
important to understand that genetic mutations are expected, and some variants can
spread and become predominant while others subside.

https://www.cdc.gov/coronavirus/2019-ncov/transmission/variant-cases.html
CDC provides daily data tracker which has maps and charts tracking cases, deaths, and
trends of COVID-19 in the United States- updated daily by 8 p.m. ET.
https://covid.cdc.gov/covid-data-tracker/#datatracker-home
For the latest CDC information
https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/index.html
Center for Medicare and Medicaid Services (CMS) +
On April 4, 2022, CMS announced that Medicare Covers Over-the-Counter COVID19 Tests- Medicare has a new initiative that will cover up to eight over-the-counter
COVID-19 tests each calendar month, at no cost to you.
https://www.cms.gov/newsroom/fact-sheets/medicare-covers-over-counter-covid-19tests
View the latest information from CMS
https://www.cms.gov/About-CMS/Agency-Information/Emergency/EPRO/CurrentEmergencies/Current-Emergencies-page
Vaccines
In this section, vaccine-related information from various sources will be collected,
reviewed, and tabulated here. As of April 5, 2022, the FDA has granted Emergency Use
Authorization (EUA) to Janssen/Johnson & Johnson. On August 23, 2021, the FDA
granted full approval to Pfizer. On January 31, 2022, the FDA granted full approval to
Moderna. Now with two vaccines with full FDA approval and one vaccine with EUA, the
goal is to vaccinate a larger number of persons in the coming months throughout the
United States. As additional vaccines are granted EUA, information for those vaccines will
also be included.
CDC created this section regarding COVID-19 vaccinations in the United States- CDC
provides overall US COVID-19 Vaccine, deliveries and administration, maps, charts, and
data updated daily by 8 p.m. This section represents all vaccine partners including
jurisdictional partner clinics, retail pharmacies, long-term care facilities, Federal
Emergency Management Agency and Health Resources and Services Administration
partner sites, and federal entity facilities.
https://covid.cdc.gov/covid-data-tracker/#vaccinations
The NYS DOH COVID-19 Vaccine Tracker Dashboard will update New Yorkers on the
distribution of the vaccine including the number of doses received by the state, a
breakdown of first or second doses, and the number of persons vaccinated with the first
and second doses in each region.
https://covid19vaccine.health.ny.gov/covid-19-vaccine-tracker
On April 4, 2022, Governor Hochul updated New Yorkers on the state's progress
combating COVID-19. Governor Hochul also received her second booster shot, the Pfizer

COVID-19 booster. Governor Hochul received a Johnson & Johnson vaccine in March
2021 and received her first booster dose, of the Moderna COVID-19 booster, in October
2021.
https://www.governor.ny.gov/news/governor-hochul-updates-new-yorkers-statesprogress-combating-covid-19-228
On April 4, 2022, Governor Hochul announced the launch of new media ads to boost
vaccination rates among children in New York State. The media rollout is just the latest
component of the New York State Department of Health’s #VaxForKids initiative,
furthering the administration's commitment to making the health and well-being of children
and families a top priority. “The COVID-19 vaccine is doctor-approved, and it is the single
best tool to keep our children and families from getting seriously ill or hospitalized,"
Governor Hochul. "This new media campaign will help ensure parents are hearing directly
from pediatricians and trusted health care providers, so they know just how critical it is to
get their children vaccinated. Parents and guardians, if you haven't already, please talk to
your child's pediatrician about getting the vaccine, and the booster dose once they are
eligible."
https://www.governor.ny.gov/news/governor-hochul-announces-launch-new-adsfeaturing-pediatricians-encouraging-parents-get-their
On April 2, 2022, Governor Hochul announced eligibility for second COVID-19 vaccine
booster doses. Booster doses are free and widely available statewide, including at all
state-run mass vaccination sites. Eligible New Yorkers may receive an mRNA vaccine—
either the Pfizer-BioNTech or Moderna COVID-19 vaccine—for their second booster shot.
"Second boosters are now available to eligible New Yorkers statewide, including at all of
the State's mass vaccination sites," Governor Hochul said. "Getting vaccinated and
staying up-to-date with all recommended doses is the most effective way to prevent
severe illness and hospitalization, and move safely forward through this pandemic."
https://www.governor.ny.gov/news/governor-hochul-announces-eligibility-second-covid19-vaccine-boosters
On March 31, 2022, Governor Hochul announced that nearly 70 million COVID-19 overthe-counter tests have been distributed by the State so far as part of ongoing efforts to
protect New Yorkers during the pandemic. "As we've seen throughout the pandemic, test
kits are a critical tool in the fight to stop the spread of COVID-19 and prevent exposure to
others," Governor Hochul said. "We have already distributed nearly 70 million COVID-19
tests, and we will continue to focus our efforts on distributing at-home tests to New
Yorkers and build up our stockpile so we can bolster our preparedness for the future,
keep our communities safe, and safely move forward through this pandemic."
https://www.governor.ny.gov/news/governor-hochul-announces-nearly-70-million-covid19-tests-so-far-distributed-new-yorkers
On March 29, 2022, Governor Hochul issued a letter to the New York Congressional
delegation illustrating the need for additional federal funding for the national COVID-19
response to ensure preparedness for future variants. This funding will help New Yorkers
continue to move safely forward through the pandemic.
https://www.governor.ny.gov/news/governor-hochul-issues-letter-new-york-congressionaldelegation-requesting-additional-federal

CDC created this section regarding the Johnson & Johnson’s Janssen vaccine to provide
updated relevant information including side effects and safety data, clinical trials
demographic statistics, and information on how the vaccine works.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/janssen.html
CDC created this section regarding the Moderna vaccine to provide updated relevant
information including side effects and safety data, clinical trials demographic statistics,
and information on how the vaccine works. As of January 31, 2022, the fully FDA
approved Moderna vaccine will now be known as SPIKEVAX for ages 18 and older.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/Moderna.html
CDC created this section regarding the Pfizer BioNTech vaccine to provide updated
relevant information including side effects and safety data, clinical trials demographic
statistics, and information on how the vaccine works. As of October 16, 2021, the fully
FDA approved Pfizer vaccine will now be known as COMIRNATY for ages 16 and older.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/PfizerBioNTech.html
HHS created this section to provide the latest information about COVID-19 vaccines.
https://www.hhs.gov/coronavirus/covid-19-vaccines/index.html
For NYC DOHMH updated guidance regarding COVID-19 vaccine
https://www1.nyc.gov/site/doh/covid/covid-19-vaccines.page
The Vaccine Finder is a one-stop site for New Yorkers to find their nearest COVID-19
vaccination location. The Vaccine Finder can also provide New Yorkers with information
to schedule vaccination appointments.
https://vaccinefinder.nyc.gov/
Educational Institution Information
• K-12
• Governor Kathy Hochul of New York announced up to $50 million in
available funding for school districts to improve student access to mental
health resources and assist students who have experienced trauma that
has impacted their education. A Request for Proposals has been issued
by the New York State Office of Mental Health, who will administer the
program. "Young students have been particularly hard-hit by the COVID19 pandemic, suffering disruptions in their education, social lives and
recreational activities and opportunities," Governor Hochul said. "I have
heard the concerns from many parents and educators about the impact
that COVID-19 has had on our children's well-being. This funding will help
ensure that every student who has experienced trauma that has impacted
their education can receive the necessary mental health resources they
need and deserve." A total of up to $10 million each year over five years
will be available and distributed to eligible school districts. Awards shall
not exceed $500,000 per applicant annually. Continued funding past the

first year will be contingent on timely reporting, satisfactory progress in
meeting chosen grant objectives, and the availability of funds.
https://www.governor.ny.gov/news/governor-hochul-announces-50million-available-increase-student-access-mental-health-services

Clinical Trials
To view the latest information on clinical trials regarding COVID-19
https://www.clinicaltrials.gov/ct2/results?recrs=&cond=Covid19&term=&cntry=&state=&cit
y=&dist=
American Red Cross
https://www.redcrossblood.org/donate-blood/dlp/plasma-donations-from-recovered-covid19-patients.html

State Updates

New York
• Governor Kathy Hochul announced the launch of applications for two tourism grant
programs designed to support and revitalize New York State's tourism and hospitality
industry. The $100 million Tourism Return-to-Work grant program and the $25 million
Meet in New York grant program were first announced in November as part of the
governor's nation-leading "Bring Back Tourism, Bring Back Jobs" initiative. Both
programs will now be making full applications available to tourism businesses,
convention and conference centers, and licensed overnight lodging facilities that have
qualified for the program. "The pandemic challenged the entire New York State business
community, but its effects were especially damaging to our tourism and hospitality
professionals," Governor Hochul said. "These programs are targeted to get help
businesses rehire workers and bring new, world-class conventions and events to our
communities - sparking the statewide economic engine that is tourism. New York is the
most exciting, most vibrant, and most engaging place on the planet, and we need to do
all we can to invite and welcome visitors from around the world."
https://www.governor.ny.gov/news/governor-hochul-announces-launch-applications-125million-relief-programs-supporting-states
• Governor Hochul announced that nearly 70 million COVID-19 over-the-counter
tests have been distributed by the State so far as part of ongoing efforts to protect New
Yorkers during the pandemic. https://www.governor.ny.gov/news/governor-hochulannounces-nearly-70-million-covid-19-tests-so-far-distributed-new-yorkers
• Governor Hochul announced eligibility for second COVID-19 vaccine booster doses.
Booster doses are free and widely available statewide, including at all state-run mass
vaccination sites. Eligible New Yorkers may receive an mRNA vaccine—either the
Pfizer-BioNTech or Moderna COVID-19 vaccine—for their second booster shot. "Second
boosters are now available to eligible New Yorkers statewide, including at all of the
State's mass vaccination sites," Governor Hochul said. "Getting vaccinated and staying
up-to-date with all recommended doses is the most effective way to prevent severe
illness and hospitalization and move safely forward through this pandemic." The State's
Department of Health released new clinical guidance on the administration of second
booster doses for all providers enrolled in the New York State vaccination program. The
guidance follows the Federal Drug Administration's (FDA) approval of Emergency Use
Authorization for a second booster and the updated recommendation from the Center for
Disease Control and Prevention (CDC) to allow adults 50 years and older to receive a
second booster of an mRNA vaccine at least four months after their first booster.
Additionally, adults ages 18 - 49 years who received the Johnson & Johnson vaccine for
their primary vaccine and initial booster dose now may receive a second booster four
months after their first booster dose. Also eligible for the second booster are New
Yorkers 12 years and older who are moderately to severely
immunocompromised. https://www.governor.ny.gov/news/governor-hochul-announceseligibility-second-covid-19-vaccine-boosters

New York State Department of Health (DOH)
For a list of positive cases by county in New York Statehttps://covid19tracker.health.ny.gov/views/NYS-COVID19-Tracker/NYSDOHCOVID-19TrackerMap?%3Aembed=yes&%3Atoolbar=no&%3Atabs=n
NYS DOH has created a dynamic COVID-19 Tracker which provides COVID-19 information
regarding testing, cases, percentages, and fatalities across New York State. It also breaks down
cases by county.
https://covid19tracker.health.ny.gov/views/NYS-COVID19-Tracker/NYSDOHCOVID-19TrackerMap?%3Aembed=yes&%3Atoolbar=no&%3Atabs=n
For the latest COVID-19 information from NYS DOH
https://coronavirus.health.ny.gov/home

New Jersey
• Governor Phil Murphy and the New Jersey Department of Education (DOE) announced
that nearly $18 million in federal American Rescue Plan (ARP) State Fiscal Recovery
Funds will be allocated to reimburse local educational agencies (LEAs) for additional
special education services provided to students who were impacted by COVID-19
related school disruptions but would otherwise have reached the maximum age of
eligibility for public school services (21 years old), as required by legislation (S3434)
signed by the Governor in June 2021. The legislation signed by the Governor in June
2021 requires LEAs to offer up to one year of additional or compensatory special
education for impacted students in the 2020-2021, 2021-2022, and 2022-2023 school
years, if a determination is made by the student’s Individualized Education Program
(IEP) team that the student requires such services. DOE did comprehensive outreach to
inform the special education community of the availability of additional services and

encouraged eligible students to opt-in to the program. The funding allocation announced
today will reimburse LEAs for the first cohort of eligible students. DOE plans to continue
comprehensive outreach efforts to ensure that the needs of the impacted student
population are met.
https://nj.gov/governor/news/news/562022/approved/20220401a.shtml

Local Updates
New York Blood Center (NYBC)
For the latest updated NYBC information about COVID-19:
https://nybc.org/covid-19/
New York City (NYC) Department of Health and Mental Hygiene (DOHMH)

NYC DOHMH launched a new variants data page. The data on this page show how variants of the
virus that causes COVID-19 are spreading in NYC. Variants are versions of the virus with certain
sets of mutations. Some variants may result in a COVID-19 infection that is easier to spread, more
severe or able to avoid antibodies from vaccines or previous infections.
https://www1.nyc.gov/site/doh/covid/covid-19-data-variants.page
For NYC DOHMH updated COVID-19 data page
https://www1.nyc.gov/site/doh/covid/covid-19-data.page
For the latest COVID-19 information from NYC DOHMH
https://www1.nyc.gov/site/doh/covid/covid-19-main.page
Westchester County Department of Health
For the latest breakdown of positive cases in Westchester County as of April 3, 2022
https://wcgis.maps.arcgis.com/apps/dashboards/280339d96db14efd9cc304dba0f3a71d
For the latest COVID-19 information in Westchester including how to avoid the latest vaccine scams
offering earlier access to vaccines.
https://health.westchestergov.com/2019-novel-coronavirus
Putnam County Department of Health
Breakdown of positive cases by towns in Putnam County as of April 1, 2022.
https://www.putnamcountyny.com/covid19/
For the latest COVID-19 information
https://www.putnamcountyny.com/health/coronavirus/
Dutchess County Department of Health
Breakdown of positive cases in Dutchess County as of April 4, 2022.
https://www.dutchessny.gov/Departments/DBCH/covid-19-dashboard.htm
For the latest COVID-19 information:
https://www.dutchessny.gov/Departments/DBCH/2019-Novel-Coronavirus.htm
Orange County Department of Health
Updated COVID-19 dashboard for Orange County, NY as of April 4, 2022.
https://ocnygis.maps.arcgis.com/apps/dashboards/21de1fb5ce0c480f95dc0cf2b8b83b71
For the latest COVID-19 information
https://www.orangecountygov.com/1906/2019-Novel-Coronavirus-Information
Rockland County Department of Health
Review Rockland County’s dashboard with the latest COVID-19 information regarding cases as of
April 1, 2022.
https://www.arcgis.com/apps/dashboards/d074e0336e81449393a76d1768ceb096

For the latest COVID-19 information
https://rocklandgov.com/departments/health/coronavirus-covid-19/
Healthcare
For the latest COVID-19 information for healthcare facilities from the Greater New York Hospital
Association that covers hospitals in the tri-state area.
https://www.gnyha.org/

Faculty News:
Even as restrictions loosen, we must all stay vigilant against COVID-19 | Opinion
LoHud
3/29/2022
https://www.lohud.com/story/news/paterson-press/2022/03/29/covid-19-restrictions-loosenbut-danger-looms/7185881001/
George W. Contreras, M.E.P., M.P.H., M.S., CEM, FAcEM, assistant director of the Center for
Disaster Medicine and assistant professor in the Institute of Public Health
New Study Says Post-COVID Brain Fog Is Real: Patch Q&A
Patch
3/28/2022
https://patch.com/new-york/pleasantville/new-study-suggests-post-covid-brain-fog-real-patchq
Stephen Ferrando, M.D., Har Esh Professor and Chair of the Department of Psychiatry and
Behavioral Sciences

Westchester Medical Center study finds COVID long-haulers suffer memory, cognitive
issues
News 12 Westchester
3/31/2022
https://westchester.news12.com/westchester-medical-center-study-finds-covid-long-haulerssuffer-memory-cognitive-issues
Stephen Ferrando, M.D., Har Esh Professor and Chair of the Department of Psychiatry
and Behavioral Sciences

Every effort is made to provide accurate and complete information in this newsletter.
However, New York Medical College cannot guarantee that there will be no errors. NYMC
makes no claims, promises or guarantees about the accuracy, completeness, or adequacy of
the contents of the newsletters or the articles linked herein and further expressly disclaims
liability for errors and omissions in the contents of this newsletter.
This newsletter is for informational purposes only; it does not constitute medical advice.
Always seek the advice of your physician or other qualified health provider with any questions
you may have regarding a medical condition.
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